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Healthy pregnancies and essential fats:
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Abstract
Background: Nut butter-based Ready to Use Supplemental Foods (RUSF) are an effective way to add nutrients and
calories to diets of malnourished and food insecure populations. The RUSF formulations have been further modified
to add micronutrients including iron and folic acid needed during pregnancy and lactation. Because
docosahexaenoic acid (DHA, C22:6 n-3) enhances fetal development and birth outcomes, it has been suggested
that perhaps RUSF formulations for pregnancy should also include this Omega 3 fatty acid. The goal of the present
study was to gain an understanding of Zambian women’s knowledge of nutritional needs in pregnancy through
structured focus group discussions, and to formulate and determine the acceptability of a RUSF with DHA.
Methods: Structured focus group sessions were conducted among women attending an antenatal clinic at the
University Teaching Hospitals in Lusaka, Zambia. Dietary and nutrition knowledge was surveyed through structured
dialogue that was recorded by audio and transcribed verbatim. An RUSF containing 400 mg DHA from fish oil in 50
g RUSF was designed and assessed for fatty acid content and product stability. Participants then sampled the RUSF-
DHA, provided feedback on taste, and were surveyed about willingness to consume the novel formula using a
standardized hedonic instrument.
Results: The participants’ knowledge of foods recommended for use in pregnancy included fruits, vegetables, meat,
and fish. Most women reported eating fish at least once per week, although the specific type of fish varied. Most
did not have prior knowledge of the importance of consuming fish during pregnancy or that some fish types were
more nutritional than others as they included omega 3 fatty acids. The participants were uniformly accepting of the
RUSF-DHA for the purpose of enhancing birth and developmental outcomes, but were critical of the aroma in
hedonic testing.
Conclusions: Women were committed to consuming a healthy diet that would impact the outcome of pregnancy,
and were receptive to advice on the importance of consuming foods such as fish as a source of DHA. The RUSF-
DHA formulation was acceptable due to the potential benefits for the developing infant, however, the fishy odor
may be limiting for long-term daily use.
Keywords: Ready to use supplemental foods (RUSF), Docosahexaenoic acid (DHA), Omega 3, Focus groups,
Hedonic assessment, Malnutrition, Food insecurity, Zambia, Pregnancy
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: cdirusso2@unl.edu
3Nebraska Center for Integrated Biomolecular Communications, Department
of Biochemistry, N241 Beadle Center, University of Nebraska-Lincoln, Lincoln,
NE 68588, USA
Full list of author information is available at the end of the article
Chunda-Liyoka et al. BMC Pregnancy and Childbirth           (2020) 20:93 
https://doi.org/10.1186/s12884-020-2783-8
Background
Maternal, infant, and child nutrition is accepted as a key
determinant of health that is vital to human capital
development and, as such, is a high priority for Sub-
Saharan Africa [1, 2]. Zambia has a population of ap-
proximately 16 million and about half of these are
women of reproductive age (15–49) [1]. More than a
third of women give birth to their first child before age
18 and 50% by the age of 20. Additionally, 10% of
women aged 15–49 are underweight (BMI < 18.5 kg/m2),
) and 14.3% of women in Zambia are living with HIV.
Low pre-pregnancy BMI, short stature and HIV are
among the risk factors for poor birth outcomes. In the
under-five age group, 14.8% are underweight and 40%
are stunted, with 17% severely stunted. It is estimated
that only 11% of children aged 6–23months are fed ad-
equately based upon recommended feeding practices [1].
About 72,000 children (0–14 years) are infected with
HIV. Due to the high rates of both malnutrition and
HIV infection in Zambia, it is essential that nutrition be
optimized to maximize development, growth, and the
ability to resist and fight infectious disease [2, 3].
Improving maternal and infant nutrition and health is
a major focus of the Zambian Government to ensure the
population reaches its full potential [1, 4]. However, the
dietary diversity for women and children in Zambia is
highly dependent upon socioeconomic status, such that
a low diversity index correlates with malnutrition and
food insufficiency [5, 6]. Animal-source foods are limited
and the diet is highly dependent on starchy staples such
as the corn-based porridge, nshima. Therefore, the basic
diet of the very low income population has limited diver-
sity, contributing to insufficient daily protein and micro-
nutrient intake, and minimal consumption of long chain
polyunsaturated n-3 fatty acids [1]. Fish is an important
staple in the Zambian diet and fish intake correlates with
dietary diversity and lower levels of stunting [2, 5, 7].
The small sardine-like fish species, kapenta, are a rich
source of DHA and native to Zambia [7]. However, in
recent years, fish has become expensive and availability
more limited, especially in urban Zambia where the bulk
of the population resides.
In cases of undernutrition, intervention and recovery
programs can help to improve nutritional status. These
often include Ready to Use Therapeutic Foods (RUTF)
that are formulated to treat moderate (MAM) and severe
acute malnutrition (SAM) [8, 9]. The base of one class
called lipid nutritional supplements (LNS) is nut paste,
generally peanut butter, that is supplemented to meet
daily macro- and micro-nutrient requirements including
the essential fatty acids [8, 10, 11]. When first developed,
the sole purpose of these lipid based RUTFs was short-
term use in SAM to raise the individual’s body weight
over 3–4 weeks after which the patient could be
transitioned to a conventional diet [10]. In actuality, due
to pervasive malnutrition and food insecurity, the thera-
peutic foods are used over months to supplement the
diet of children with MAM and SAM under the age of
five and pregnant or lactating women [11, 12]. This has
led to the development of Ready to Use Supplemental
Foods (RUSF) that provide the daily requirement for es-
sential micronutrients, and a lesser amount of the mac-
ronutrients, to bring added value to the daily food intake
and enhance, but not replace, a conventional diet.
One point of concern with the lipid-based RUTFs is
that the essential polyunsaturated fatty acids in these
food supplements are from plant oils and include only
linoleic acid (LA n-6) and linolenic acid (LN n-3). These
two fatty acids must be further processed in the body to
make the long chain polyunsaturated fatty acids arachi-
donic acid (AA n-6), eicosapentaenoic acid (EPA n-3)
and docosahexaenoic acid (DHA n-3). This biological
process is inefficient in humans [13]. Because DHA is a
building block for fetal brain growth, large amounts are
required during fetal development and for 24 months
after birth [14]. When a pregnant woman is food inse-
cure, her fetus, and later her infant, are at risk for sub-
optimal brain development and function. If both food
insecure and living with HIV, fetal brain development
and function are further at risk [2, 15, 16]. Therefore,
there is much interest in developing dietary supplements
that include DHA, during pregnancy and lactation, to
support neuronal development [17, 18].
Given the high rate of malnutrition and stunting in
Zambia and the value of RUSF for use in addressing
some of the nutritional problems of women and their in-
fants, we developed an RUSF with fish oil to supply the
DHA crucial to fetal and infant brain growth. The goals
of the present study were to assess the knowledge of
pregnant women about what foods are required during
pregnancy for maximizing fetal development and, more
specifically, to address knowledge about the need for es-
sential fatty acids including DHA in the diet for brain
development. Employing focus group discussions sur-
rounding nutrition and health, as well as hedonic testing
of the RUSF-DHA, the current study presents findings
on nutrition knowledge for pregnancy and the accept-
ability the peanut butter-based RUSF with fish oil to
pregnant women in Zambia.
Methods
Study site
This work was a collaboration between the University
Teaching Hospitals (UTHs), Lusaka, Zambia and the
University of Nebraska, Lincoln, Nebraska, U.S.A. Ex-
perimental design, ethical conduct of the research, and
the data sharing plan were approved by Institutional Re-
view Boards at each institution to comply with Zambian
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and US laws (UNZAREC IRB #00005948 and UNL IRB
#20170416833FB). Experimental design met NIH pol-
icies regarding conflict of interest, biosafety, human par-
ticipant research, data collection and analysis, and
confidentiality.
This study took place in Lusaka, Zambia, at the UTHs,
which are part of a complex of hospitals that include the
Women and Newborn Hospital, Children’s Hospital,
Adult and Emergency Hospital, Eye Hospital and Cancer
Diseases Hospital. Lusaka is the largest city in Zambia
with a population of about 2.4 million inclusive of the
metropolitan area, which is 15% of the total national
population. The UTHs comprise the largest health care
center in the country. The Women and New Born Hos-
pital of the UTHs facilitate approximately 60–80 ante-
natal clinic screenings performed per day and 900–1000
deliveries per month, on average, providing a large pa-
tient population pool for the studies reported here.
Participants
All participants were recruited from the antenatal clinic
of the Women and Newborn Hospital in Lusaka. The in-
dividuals were selected for participation in the focus
group at random from a pool of approximately 150
women being recruited for a larger preclinical trial. The
participant pool was made up of women of reproductive
age who were pregnant and of a typical pre-pregnancy
body mass, i.e., between 18 and 25 kg/m2 and neither
over- or under-weight. Referral for participation was
made through collaborating medical doctors in the UTH
Women and Newborn Hospital antenatal care clinic
(ANC). Information about the study was verbally given
to potential participants by study nurses and/or doctors.
Those that understood and accepted the invitation were
asked to provide written informed consent to be in-
cluded in the study.
Focus group site and procedures
The sessions were held in the ANC meeting and training
room. The room was an open space with rows of
benches used for antenatal lessons and clinic appoint-
ment registration holding about 60–80 persons at cap-
acity. The focus groups were held at times when the
room was not scheduled for other purposes. However,
the outside entrance was at the back of the room, conse-
quently, some individuals who were not participating
could enter or exit during focus group sessions. The
number of non-participants never exceeded 5–10 and
these individuals stayed at the back of the room away
from the discussions. Non-participants were instructed
to remain silent during session conversations.
Three focus group sessions with 7–10 participants (to-
taling 27) were held on 3 different days between Septem-
ber and November 2017. This number was considered
adequate to engage participants in a conversation with-
out inhibiting more reticent individuals [19]. A core
team of professionals ran the sessions and included two
physicians (authors MKL and MI), one study nurse and
one nutritionist. All had experience in conducting ses-
sions of this type for the purpose of teaching and re-
search. Only the nutritionist was male, and although
session leadership roles varied, the same professionals
participated in all 3 sessions using the same script. The
predominant language used during focus groups was
Nyanja with some English, which was understood by
most participants. In one of the groups, there was a cli-
ent who could not understand Nyanja/English, so
Bemba had to be used as well. An audio recording was
made of each session after informing the clients that dis-
cussions would be recorded. The 3 session recordings
were translated to English by a professional translator
and verified by one investigator (MKL). Additionally, a
video recording was made of one session for archival
purposes.
Focus group discussion guides
The transcript of the focus group discussion is available in
Additional file 1 and is outlined in Table 1. Briefly, the intro-
duction welcomed the participants and instructed them on
the purpose of the meeting, the manner in which discussions
were to be conducted, and explained that the sessions would
be recorded by audio taping. Then the discussion proceeded
around questions about food consumption patterns and nu-
tritional intake during pregnancy, as well as the intake of fish.
Subsequently, the RUSF-DHA was offered for hedonic as-
sessment and discussion of probable acceptance and use as a
dietary supplement in pregnancy.
Analysis of Focus Group Responses.
The transcripts from the 3 focus group sessions were
assessed independently by 3 of the study investigators
using content analysis methods [20]. The coding units
were established a priori for the quantitative data and the
script of the sessions was based on the various categories
developed into questions as listed in Table 1. Coding cen-
tered on 4 themes: knowledge of nutritional needs in
pregnancy; knowledge of fish intake for omega 3 DHA
consumption; familiarity with RUSF; acceptability and pal-
atability of new RUSF-DHA. After the 3 analysts rated the
responses independently, a summative response database
was generated and then employed to yield Table 2.
To assess the acceptability of the RUSF-DHA, each
participant was offered a 50 g sachet to taste the product
and asked to verbally express their response for aroma,
texture, flavor, aftertaste, and overall attributes. Each
participant also recorded their response on a 9-point he-
donic testing instrument. The data were assessed using
least squares means.
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Formulation and analysis of the RUSF-DHA
The Ready to Use Supplemental Food with DHA
(RUSF-DHA) formulation was based on World Health
Organization guidance [8]. The base was peanut butter
and supplements were formulated as in iLiNS [21]. A
dosage of 400 mg DHA in 50 g RUSF was selected, based
on previous studies that recommended this level of
DHA to maximize birth outcomes [22]. To supply this
level of DHA, the RUSF was supplemented with 5.22%
Meg-3™ ‘30’ n-3 Food Oil, a highly refined tuna oil that
has a minimum of 9% EPA and 12.5% DHA (DSM Nu-
tritional Products, Inc.). The formulation was prepared
in the factory of Edesia Nutrition, Inc. (Kindstown, RI)
and transported to Zambia by express shipping.
Each batch of RUSF-DHA was evaluated for fatty acid
content after Folch extraction, acid hydrolysis and con-
version to methyl esters using gas chromatography and
mass spectrometry as is standard in the DiRusso labora-
tory [23]. A commercial thiobarbituric acid reactive sub-
stances (TBARS) analysis kit was used to measure lipid
peroxidation (Sigma-Aldrich, St. Louis, MO, USA) of the
RUSF-DHA product.
Results
Focus group assessment regarding dietary practices and
knowledge of nutrition
Participants were enrolled during antenatal clinic visits
for sessions being held that day. In total, 3 sessions were
convened. Twenty seven women, 7 in the first session,
and 10 in sessions two and three, participated in the
focus group and subsequent RUSF-DHA taste test. All
participants were between 18 and 41 years of age, 16 to
34 weeks of gestation, and 18 to 25 kg/m2 of body mass
index. Approximately 50% of the women had completed
secondary schooling, while 18% had completed only pri-
mary school. The remaining participants had some ter-
tiary education and training. An outline and summary of
the Interview Guide procedures and questions for the
discussions are presented in Table 1 and the complete
focus session transcript appears in Additional file 1.
The knowledge of the participants regarding nutri-
tional needs during pregnancy was assessed by querying
information about what special foods and supplements
including vitamins should or should not be ingested dur-
ing pregnancy. There was a general consensus in each
focus group session that non-fatty foods, dairy products
as a source of calcium, and foods containing iron should
be consumed on a daily basis (Table 2). The foods cited
as containing these nutrients included milk, yogurt, liver,
fish or kapenta. Other foods noted that should be eaten
during pregnancy included fruits and vegetables, ground
nuts, beans and nshima, a corn-meal based porridge that
is a staple of the local diet.
All participants acknowledged that vitamin supple-
ments are recommended during pregnancy for the
health of the child, and further reported that these were
provided at no cost at the antenatal clinic or might be
purchased at a pharmacy. Referring to the free vitamin
supplements, one participant commented that,
“Yes, always when someone is pregnant they are
given vitamins although we can’t know what they do
Table 1 Layout of the Interview Guide
1. Introduction
1.1. Welcome and thank the participants for their participation
1.2. Introductions of the discussion leader and observers
1.3. Describe the purpose of the Focus Group and DHA discussion
1.4. Establishing ground rules for the discussion
1.5. Informing about session recording by audio only or audio and
video
2. Questions regarding food and nutrition during pregnancy
2.1. Are there any special foods purchased or prepared especially for
pregnant women?
2.2. Do pregnant women need to take vitamins?
2.2.1. Why or why not?
2.3. How many of you are taking vitamins while you are pregnant?
2.4. Where do you get them? Do you pay for them or are they free?
2.5. Are there any foods that women should not eat when they are
pregnant? Why?
2.6. What should women eat to stay healthy when they are
breastfeeding?
3. Questions regarding fish intake
3.1. Do you eat Kapenta and fish?
3.2. How often do you buy Kapenta and fish in your home?
3.3. How often do you eat it in a week?
3.4. What type of fish and Kapenta do you eat?
4. Questions regarding RUSF (asked while smelling and tasting the
product).
4.1. Do you have any allergies to the ingredients in the packet?
4.2. How does it taste?
4.3. Do you think other pregnant and breastfeeding women would
like it?
4.3.1. Why or why not?
4.4. How often would a pregnant or breastfeeding mother eat a
product like this?
4.5. How do you think you might eat this product?
4.6. What foods might you eat it with or mix it with?
4.7. What do you like about the product?
4.8. Any problems or disadvantages with this product?
4.9. What could be changed about it?
4.10. Overall, do you like this product?
5. Please fill out the questionnaire (i.e. hedonic survey) about the
product.
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with them at home whether they throw or they take
them”. F01-R1
There was a general acknowledgement that vitamins are
particularly important when food is limited on a daily
basis. Specific vitamins mentioned included vitamin C
and B12. A need for calcium and iron supplementation
was mentioned in two of the sessions. However, despite
the access and knowledge about vitamins, not every
woman was taking them daily. A respondent stated,
“ … there is no need to take since we already have a
good appetite for food”. F02-R1
Participants indicated that some foods and beverages should
be avoided, including those that are high in salt and fat, soft
drinks, and alcohol. Smoking was also discussed for its nega-
tive health impacts. One participant commented that,
“she can eat anything unless if its causing her to
have nausea.” F01-R2
This comment initiated a discussion of the negative im-
pact on appetite of strong odors and flavors during preg-
nancy. There was also a discussion in one group about the
practice of eating dirt or clay, a practice that is common
in some cultures [24–26]. The participants acknowledged
that this practice was discouraged by healthcare workers.
Assessment of fish consumption and knowledge of health
benefits of fish
Certain fish species are a natural nutritional source of
DHA [7, 27]. Therefore, fish intake was extensively
queried and discussed. Those participants that ate fish
did so on average 2–3 times per week; one participant
said she eats it every day and one did not eat fish at all.
Fish was acknowledged as being a good nutritional
staple during pregnancy, but not specifically as related
to brain or cognitive development of the fetus or infant.
That information was provided by the focus group fa-
cilitators as part of the introduction describing the pur-
pose of the focus group and importance of DHA intake
for infant development (Additional file 1). The com-
mon fish species purchased and consumed were:
bream made up of common types of cichlidae similar
to tilapia; mpulungu buka (Lates stappersi); kapenta, a
type of fresh water sardine (Limnothrissa miodon and
Stolothrissa tanganicae); and chisense (Neobola nwer-
uensis). One participant mentioned eating mackerel.
Of these, kapenta, chisense and mackerel contain sig-
nificant amounts of DHA (10% or more of the total
fatty acids) [7, 27]. Kapenta intake was specifically
queried in the survey for this reason. Intake varied
from none to 2–3 times per week. It should be noted
most respondents who ate fish generally mentioned
bream and buka, which are not significant sources of
DHA [27, 28].
RUSF formulation
A major goal of this work was to develop and assess an
RUSF to contain fish oil as a method to deliver macro-
nutrient and micronutrient supplements and DHA to
women at risk for food insecurity and malnutrition dur-
ing pregnancy and lactation since this is a concern in
Zambia [5, 29]. The lipid based nutrient supplements
are deemed a valid delivery vehicle for DHA as the oils
are miscible in the nut paste, low in water, as well as air
and light tight, which helps to maintain the integrity of
the highly unsaturated fatty acids to prevent or reduce
oxidation [30]. The base of the RUSF-DHA developed
for this study was peanut butter, supplemented with
non-fat milk and whey powders, sugar, and mixed nat-
ural tocopherols as preservatives with a vegetable oil
mixture as listed in Table 3. Additional micronutrients,
including minerals and vitamins, were added as recom-
mended [8]. Preliminary formulation tested DHA levels
at 300, 600 or 900 mg per 20, 50 or 75 g of RUSF. We
sought the highest dose palatable, based on aroma and
taste in small group tastings at Edesia, Inc. and UNL.
The 300–600 mg doses were equally accepted, while the
900 mg dose was rated as having the strongest “fishy”
odor and aftertaste. The final formulation of approxi-
mately 400 mg DHA per 50 g supplement was selected
to reach levels informed by studies in the US and else-
where as suitable for optimal birth and infant develop-
mental outcomes [14, 22, 31–35].
Fatty acid analysis of the final product indicated about
half of the fat was monounsaturated, primarily oleic acid
and about 13.5% was the saturated fatty acid palmitate
(Table 4). The polyunsaturated fatty acids (PUFA) (lino-
leate and linolenate) comprised about 50% of the total
fatty acids and the long chain highly unsaturated PUFA
were 3% total. As expected of the latter, arachidonic acid
levels were low at 0.24 mol% since an enriched source of
this long chain PUFA was not added, while EPA and
DHA were 0.57 and 2.3 mol% total FA, respectively,
from the fish oil. Since oxidation of DHA and other un-
saturated fatty acids could lead to reduced palatability
and unfavorable odors (i.e. “fishiness”), a commercial
assay was performed, which demonstrated no significant
increase in oxidized lipids over 6.5 months storage with
temperature (Fig. 1).
Comments on the RUSF-DHA while sampling the food
After the discussion of diet and nutrition information, the
participants were offered a 50 g sachet of the RUSF-DHA
to taste, smell, and sample. Impressions of the food prod-
uct were recorded and transcribed from the discussions
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Table 4 Fatty acid analysis of RUSF-DHA
mg/50 g Serving (SEM)1
Fatty Acid RT (To) RT (T6.5) 30 °C (T6.5) 40 °C (T6.5)
Myristic C14:0 74.2 (2.71) 77.06 (2.55) 75.13 (1.50) 73.77 (1.34)
Palmitic C16:0 1762 (34.92) 1860.6 (28.97) 1716.44 (7.96) 1708.17 (17.2)
Palmitoleic C16:1 94.73 (2.32) 100.30 (0.53) 96.59 (2.47) 97.31 (1.53)
Stearic C18:0 771.07 (14.09) 810.53 (11.99) 763.54 (2.78) 756.51 (3.85)
Oleic C18:1 7032.46 (172.12) 7535.15 (83.29) 6895.01 (124.53) 6870.18 (130.09)
Linoleic C18:2 n-6 2490.37 (52.82) 2639.32 (26.96) 2510.33 (54.07) 2523.96 (37.58)
Linolenic C18:3 n-3 787.94 (16.77) 827.30 (9.78) 806.42 (21.66) 816.78 (9.97)
Arachidonic C20:4 n-6 36.89 (0.95) 36.9 (1.03) 36.43 (1.80) 35.57 (0.29)
Eicospentaenoic C20:5 n-3 84.34 (2.61) 91.1 (1.37) 87.43 (2.20) 88.51 (1.17)
Docosahexaenoic C22:6 n-3 375.52 (11.79) 386.50 (11.69) 402.38 (10.70) 405.17 (5.83)
Relative mol%
SFA C14 + C16 + C18 19.61 (0.08) 19.44 (0.07) 19.36 (0.24) 19.26 (0.14)
MUFA C16:1 + C18:1 50.1 (0.2) 50.49 (0.06) 49.49 (0.18) 49.35 (0.19)
PUFA C18:2 + C18:3 23.21 (0.07) 23.09 (0.04) 23.64 (0.17) 23.83 (0.03)
HUFA C20:4 + C20:5 + C22:6 3.08 (0.04) 3 (0.05) 3.28 (0.04) 3.3 (0.02)
n-6:n-3 2.11 (0.01) 2.14 (0.01) 2.05 (0.02) 2.04 (0.04)
1RT, room temperature; 6.5 indicates the number of months in storage at the indicated temperature. SFA, saturated fatty acid; MUFA, monounsaturated fatty acid;
PUFA, polyunsaturated fatty acid; HUFA, highly unsaturated fatty acid
Table 3 Composition of the RUSF-DHA (50 g serving)
Ingredients Contents
Non-hydrogenated vegetable oil (containing soybean
oil, canola oil, palm oil), peanuts, nonfat milk powder,
sugar, whey powder, Meg-3™ ‘30’ n-3 INF Oil (refined
fish oil from tuna), identity preserved mixed natural
tocopherols, ascorbyl palmitate, stabilizer (hydrogenated
vegetable fat), and vitamin and mineral complex.
Amount/50 g kcal/50 g
Fat 20.4 g 184
Protein 6.8 g 27
Carbohydrate 21.4 86
Calories 297
Meg-3™ ‘30’ n-3 INF Oil 5.22% (400mg DHA)
Iron 22 mg
Vitamin C 90 mg
Folic Acid 600 mcg
Iodine 330 mcg
Water Activity 0.367
Enterobacteriaceae < 10 cfu/10 g
Salmonella 0 cfu/375 g
Total Aflatoxin < 0.2 ppb
RUSF-DHA formulation by Edesia Nutrition, Inc., Kingstown, RI. Note, not all micronutrients listed
Chunda-Liyoka et al. BMC Pregnancy and Childbirth           (2020) 20:93 Page 9 of 14
(Table 2) as well as recorded in a standardized hedonic
test (Table 5). None of the participants had any noted al-
lergies to the product ingredients, although one indicated
a problem with intestinal gas after eating dried fish and
another said she generally limits soy products. The most
negative remarks revolved around the aroma, which was
felt to be too “fishy”. For example, remarks included:
“the taste is just fine only the smell is what I don’t
like”. F03-R5
Most participants felt the taste was acceptable, although
a few thought the taste was salty and sweet, which is a
common response of adults to lipid-based RUTFs. The
texture was acceptable to all.
The participants were asked how often they thought a
pregnant or breastfeeding mother would eat this product.
Table 5 Summary of focus group responses to sensory test (27 participants)
Attribute Hedonic Scale* Mean
(Range)
Oral Comments Written Comments
Aroma 4.41 (1–9) Don’t like the fish smell Aroma needs to be changed
Bad smell Smell is unfavorable
Aroma is not very appealing
There is a fish smell
Aroma should be changed
Texture 8.30 (4–9) It’s okay, smooth and thick Texture is OK
Texture is good
Flavor 7.07 (2–9) Taste is just fine Flavor is OK
If the peanut butter taste were stronger than the fish it could
be much better
Flavor is moderately nice
Like all of the flavors
Aftertaste 4.11 (1–9) Bad aftertaste of fish Aftertaste is OK
Peanut butter aftertaste Aftertaste is unfavorable
Aftertaste is not very nice
Overall 7.11 (1–9) Pregnant and breastfeeding mothers can take it because it’s
good for the child’s health
Sugar level is too much
Would eat daily without the fish smell I like the product and everything is okay
It is good because it helps the child with development of the
brain and good sight
They are all fine. It has the benefit for my baby.
The product is okay
It has got all the vitamins we need
The sample is generally good as it seems to
contain all nutrients
Likes
overall
7.64 (6–9) The peanut butter taste Like it because it has good advantages
The product helps the child The product is okay if the fish smell can be
reduced
Dislikes
overall
1 (1 respondent) Fishy/oily taste and smell Aftertaste is not great
Smell is fishy
Texture is too thick
Least squares means for the aroma, texture, flavor, aftertaste, and overall attributes of the RUSF using a 9-point hedonic scale, *where 9 = Like Extremely, 8 = Like
Very Much, 7 = Like Moderately, 6 = Like Slightly, 5 = Neither Like nor Dislike, 4 = Dislike Slightly, 3 = Dislike Moderately, 2 = Dislike Very Much and 1 = Dislike
Extremely. Attributes were assessed by focus group participants
Fig. 1 Estimation of lipid peroxidation after storage. RUSF-DHA
samples were stored at various temperatures for 6.5 months. There is
no significant difference between samples (One way ANOVA (p =
0.69; JMP Pro v12))
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The answers varied from only once per week, because of
the smell, to three times a day if the fish odor could be
limited. Most participants agreed that the RUSF-DHA
would be more likely to be acceptable for every day intake
if mixed with another food such as rice or eaten as a
spread on bread.
While many participants expressed some concern
about the smell and flavor, it was generally agreed that
the health benefits to the developing child would take
precedence over taste and smell to drive the individuals
toward acceptance. In hedonic testing, the flavor actually
rated quite high at 7/9, while the aftertaste was rated as
moderate at 4/9 on a scale of 9 (like extremely) to 1(dis-
like extremely) (Table 4). Generally, the participants
agreed that if the RUSF-DHA provided nutritional bene-
fit to the child’s development, then it would be accept-
able to pregnant and lactating women. One stated,
“I like it because it’s important for the child’s health
which is critical, mothers should take it”, F01-R6
and another,
“I don’t like it but just the nutrients will make me
take it.” F02-R6
Additionally, it was mentioned that the smell might be
less objectionable during lactation, rather than during
pregnancy when certain foods and odors can initiate
nausea:
“I think the ones who are breastfeeding can like the
product more than the pregnant mothers because
pregnant mothers become too choosey with food.”
F02-R3
Discussion
In the present work, we interrogated knowledge about nu-
trition during pregnancy and eating habits of pregnant
women in an antenatal clinic population in Zambia where
there are high rates of food insecurity, malnutrition, and
stunting. We also developed and evaluated acceptability of
a lipid based-RUSF formulation that contained fish oil to
provide a source of DHA. The RUSF-DHA was designed
for use by malnourished women during the first 1000
days, from conception through 24months, during the crit-
ical period of brain and neuronal development [14]. The
DHA dosage was based on studies in the U.S. and else-
where that were aimed at evaluating DHA for improved
birth, cognitive, and developmental outcomes for women
and their infants [15, 34, 36–38].
During the focus group sessions, participants generally
expressed knowledge that certain food groups are re-
quired for the health of the developing child, including
vegetables, fruit, milk and dairy products, beans, corn
meal porridge, meat, and fish. The responses reflected
the fact that the importance of a nutrient-rich diet dur-
ing pregnancy was generally acknowledged. Nutrition
counseling is routinely incorporated as part of the pre-
natal program offered by the UTH ANC in Lusaka.
Thus, the women were receptive of a relatively new con-
cept that certain fats, namely DHA, were also important
for brain development of the child before and after birth.
In fact, the value of the nutrient, DHA, drove the accept-
ability of the RUSF, even though the sensory testing re-
vealed a dislike for the smell of the food and some
aspects of the taste including an aftertaste.
Since the supplement should be consumed daily over
months during pregnancy and lactation, we also sought
to determine acceptability in a population at high risk
for food insecurity. The final formulation contained ap-
proximately 400mg DHA per 50 g serving. The most
common criticisms of the product were that it had a
fishy smell and taste. Despite this finding, the product
was found to be acceptable because of its potential value
to healthy birth and developmental outcomes for the
child. Ultimately, the development of the child took pre-
cedence over the mothers’ tastes. It was generally agreed
that the 50 g supplement would be consumed for this
reason, especially if added to another component of a
standard diet such as rice or bread.
It is noteworthy to mention that, while the RUSF-
DHA product was designed for use by individuals at risk
for chronic malnutrition, the participants in this study
were not clinically malnourished as all fell within the
range of body-mass index (BMI) between 18 and 24 pre-
pregnancy. However, the need for the product by this
clinic population overall is justified as it was determined
during enrollment that within the general client base of
the clinic, 23% (168/735) of women visiting for the first
prenatal screening were clinically malnourished with a
pre-pregnancy BMI ≤ 16. The national population aver-
age in Zambia for malnutrition is 17%, thus these mal-
nourished women were excluded from the focus group
panels to meet the inclusion criteria. However, the mal-
nourished population is the ultimate target for the RUSF
being developed to provide one supplement that will
meet all the various micronutrient needs of women dur-
ing pregnancy and lactation [24]. Additional studies are
underway in Zambia to assess the DHA status of preg-
nant women and to examine the possible additional con-
sequences of infectious disease including Human
Immunodeficiency Virus (HIV) where prevalence is 22%
of pregnant women [1].
Both women and children diagnosed with severe or
moderate malnutrition have positive outcomes when
provided Ready to Use Therapeutic or Supplemental
Foods (RUTF and RUSF, respectively) as part of their
Chunda-Liyoka et al. BMC Pregnancy and Childbirth           (2020) 20:93 Page 11 of 14
therapeutic care [8, 12, 24, 39, 40]. Studies surrounding
such small quantity lipid based nutritional supplements
(LNS) were the focus of the International Lipid-Based
Nutrient Supplements Project (iLiNS), which sought to
evaluate a wide variety of impacts using various formula-
tions of small quantity LNS (i.e. 20 g total daily) [11].
Encouraging outcomes of some these trials included, for
example, increased birth size and length of infants of
primiparous women in Ghana taking a small quantity
(20 g) RUSF daily from 20 weeks gestation until delivery
[21, 41, 42]. Thus, RUSF are often recommended in
chronic malnutrition to add essential nutrients to the
standard diet during food insecurity. Supplemental feed-
ing projects like the completed Rainbow Project in
Zambia further provide evidence for the value of RUTF
use [43]. Overall, in the present study the participants dis-
played a general knowledge of the types of food that are
recommended for consumption during pregnancy to pro-
vide adequate nutrient intake for mothers and infants.
Some of this nutritional advice had been provided by the
staff of the ANC during clinic visits. While eating fish to
provide specific nutrients like DHA was not necessarily a
component of the participants’ prior knowledge base, fish
are part of the standard diet for the population and are
eaten by most 2–3 times per week. However, the type of
fish purchased and consumed was variable and some com-
monly mentioned types including bream and buka that
are not a good source of DHA [7, 27].
Common sources of high DHA oils include certain species
of fish (e.g. salmon, tuna, sardines) and/or algae [44–46]. In
Western cultures, dietary DHA levels are generally very low
and dietary supplementation for pregnant and lactating
women and infants is highly recommended [14, 16, 47]. No
studies have evaluated RUTF or RUSF supplemented with a
DHA containing oil and only one has evaluated the combin-
ation of RUTF and fish oil capsules in a clinical trial setting
[48]. Therefore, it remains controversial as to whether or not
there is value in adding DHA and/or limiting the ratio of n-6
to n-3 fatty acids to improve health outcomes with these
food supplements. Additionally, not all food insecure popula-
tions may require DHA supplementation. For example, if the
traditional diet includes fish high in DHA as a dietary staple,
as is true in Malawi, such supplementation would be un-
necessary [49]. Therefore, it will be important to test the
need for the product based on assessment of the omega 3
index in blood in the underweight and malnourished popula-
tion of Zambian women. If low, then supplementation with
the RUSF-DHA for outcomes related to fetal and infant de-
velopment, as well as birth outcomes, must also be evaluated
in future studies.
There were limitations to this focus group study, includ-
ing the small numbers of participants. The size of the
groups was kept low at 7–9 individuals to encourage con-
versation and participation by all members of the group.
The final number at 27 individuals followed recommenda-
tions for this type of survey of climate and knowledge sur-
rounding dietary behaviors and knowledge of nutrition
[19]. The room chosen for the discussion sessions was also
suboptimal as non-participants could not be excluded
from the room. The population of participants was limited
to the greater urban area of Lusaka. Additional focus
groups are planned for rural locations in the future. Lan-
guage may also have been a barrier to some individuals as
the introduction and discussion questions had to be trans-
lated by the group facilitators to accommodate all partici-
pants. Despite these limitations, this study provided useful
insight into the beliefs and practices of nutrition in preg-
nancy among ANC UTH clients.
Conclusions
The participants expressed willingness to accept new in-
formation regarding the need for essential fatty acids,
particularly DHA, for the health of their infants during
pregnancy and lactation. It was apparent that additional
knowledge regarding the benefits of fish as a source of
protein, vitamins, and essential fatty acids is needed as
part of the nutrition and clinical services provided. Spe-
cifically, there should be education about including those
types of fish that are high in DHA such as kapenta in
the standard diet. As mentioned above, it is also critical
to conduct additional studies to evaluate DHA supple-
mentation as the RUSF-DHA for food insecure and mal-
nourished women in pregnancy and lactation. For the
well-nourished population, increased levels of DHA in-
take should be encouraged by counseling to eat kapenta
and other high DHA-containing fish.
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